Insider trades occur when company insiders, such as executives, directors, or significant shareholders (owning more than 10% of a company's equity securities), buy or sell securities of their own company. In the United States, these trades must be reported to the Securities and Exchange Commission (SEC). Legal insider trading is permissible and common. However, insider trading becomes illegal when based on material, non-public information about the company. The SEC closely monitors these trades for suspicious activity, and investors track insider trades as they can provide insights into a company's prospects and performance. Below you will find insider screener’s insider trading tracker, which covers the United States and other major stock markets around the world.
Your saved searches
You have no saved searches
Search 1 filter applied
Notification date | Transaction date | Company | B/S Transaction type | Insider and/or position |
Nb. shares Price Value |
Number of shares | Price | Value | Details |
---|---|---|---|---|---|---|---|---|---|
2025-01-17 | 2025-01-17 |
Marvell Technology Inc
(MRVL)
|
PS Planned sale |
Casper Mark EVP & Chief Legal Officer Officer |
7,755
-100.0%
123.08USD 954,485 |
7,755 -100.0% | 123.08 | USD 954,485 | |
2025-01-17 | 2025-01-17 |
New York City REIT Inc
(NYCI)
|
B Purchase |
SCHORSCH NICHOLAS S Large shareholder |
1,367
+0.1%
9.21USD 12,590 |
1,367 +0.1% | 9.21 | USD 12,590 | |
2025-01-17 | 2025-01-17 |
Adaptimmune Therapeutics PLC
(ADAP)
|
S Sale |
Rawcliffe Adrian Chief Executive Officer Executive Director |
30,601
-40.8%
0.58USD 17,773 |
30,601 -40.8% | 0.58 | USD 17,773 | |
2025-01-17 | 2025-01-17 |
Adaptimmune Therapeutics PLC
(ADAP)
|
S Sale |
Norry Elliot Chief Medical Officer Officer |
5,584
-42.6%
0.58USD 3,243 |
5,584 -42.6% | 0.58 | USD 3,243 | |
2025-01-17 | 2025-01-17 |
Adaptimmune Therapeutics PLC
(ADAP)
|
S Sale |
Lunger John Chief Patient Supply Officer Officer |
5,584
-42.6%
0.58USD 3,243 |
5,584 -42.6% | 0.58 | USD 3,243 | |
2025-01-17 | 2025-01-17 |
Adaptimmune Therapeutics PLC
(ADAP)
|
S Sale |
Bertrand William C JR Chief Operating Officer Officer |
5,584
-42.6%
0.58USD 3,243 |
5,584 -42.6% | 0.58 | USD 3,243 | |
2025-01-17 | 2025-01-17 |
Compass Inc
(COMP)
|
PS Planned sale |
Reffkin Robert L. Chairman and CEO Executive Director |
42,717
-2.1%
6.90USD 294,918 |
42,717 -2.1% | 6.90 | USD 294,918 | |
2025-01-17 | 2025-01-17 |
Yellowstone Acquisition Co
(YSAC)
|
S Sale |
BOSTON OMAHA Corp Large shareholder |
7,861
-0.1%
11.36USD 89,292 |
7,861 -0.1% | 11.36 | USD 89,292 | |
2025-01-17 | 2025-01-17 |
Madrigal Pharmaceuticals Inc
(MDGL)
|
S Sale |
Kelley Shannon T General Counsel Officer |
277
-3.5%
273.41USD 75,735 |
277 -3.5% | 273.41 | USD 75,735 | |
2025-01-17 | 2025-01-17 |
Madrigal Pharmaceuticals Inc
(MDGL)
|
S Sale |
Taub Rebecca Pres., R&D, and CMO Executive Director |
1,689
-0.4%
273.41USD 461,789 |
1,689 -0.4% | 273.41 | USD 461,789 | |
2025-01-17 | 2025-01-17 |
Madrigal Pharmaceuticals Inc
(MDGL)
|
S Sale |
Waltermire Robert E. Senior VP, Chief Pharma Dev. Officer |
442
-8.0%
273.41USD 120,847 |
442 -8.0% | 273.41 | USD 120,847 | |
2025-01-17 | 2025-01-17 |
ON24 Inc
(ONTF)
|
PS Planned sale |
Vattuone Steven Chief Financial Officer Officer |
1,022
-0.2%
6.50USD 6,646 |
1,022 -0.2% | 6.50 | USD 6,646 | |
2025-01-17 | 2025-01-17 |
Tempus AI, Inc.
(TEM)
|
S Sale |
KEYWELL BRADLEY A Large shareholder |
148
-0.0%
35.79USD 5,298 |
148 -0.0% | 35.79 | USD 5,298 | |
2025-01-17 | 2025-01-17 |
Tempus AI, Inc.
(TEM)
|
S Sale |
KEYWELL BRADLEY A Large shareholder |
264,852
-1.7%
35.10USD 9,296,861 |
264,852 -1.7% | 35.10 | USD 9,296,861 | |
2025-01-17 | 2025-01-17 |
AGBA Acquisition Ltd
(AGBA)
|
S Sale |
Diamond Robert E. Jr. Non-Executive Director |
120,000
-12.7%
2.46USD 295,200 |
120,000 -12.7% | 2.46 | USD 295,200 | |
2025-01-17 | 2025-01-17 |
Atlassian Corp
(TEAM)
|
PS Planned sale |
Farquhar Scott Non-Executive Director Large shareholder |
100
-0.0%
258.43USD 25,843 |
100 -0.0% | 258.43 | USD 25,843 | |
2025-01-17 | 2025-01-17 |
Atlassian Corp
(TEAM)
|
PS Planned sale |
Farquhar Scott Non-Executive Director Large shareholder |
2,898
-0.7%
253.05USD 733,331 |
2,898 -0.7% | 253.05 | USD 733,331 | |
2025-01-17 | 2025-01-17 |
Atlassian Corp
(TEAM)
|
PS Planned sale |
Farquhar Scott Non-Executive Director Large shareholder |
1,756
-0.4%
254.00USD 446,019 |
1,756 -0.4% | 254.00 | USD 446,019 | |
2025-01-17 | 2025-01-17 |
Atlassian Corp
(TEAM)
|
PS Planned sale |
Farquhar Scott Non-Executive Director Large shareholder |
150
-0.0%
254.85USD 38,228 |
150 -0.0% | 254.85 | USD 38,228 | |
2025-01-17 | 2025-01-17 |
Atlassian Corp
(TEAM)
|
PS Planned sale |
Farquhar Scott Non-Executive Director Large shareholder |
3,044
-0.8%
252.14USD 767,521 |
3,044 -0.8% | 252.14 | USD 767,521 | |
2025-01-17 | 2025-01-17 |
Atlassian Corp
(TEAM)
|
PS Planned sale |
Cannon-Brookes Michael CEO, Co-Founder Executive Director Large shareholder |
3,044
-0.8%
252.14USD 767,521 |
3,044 -0.8% | 252.14 | USD 767,521 | |
2025-01-17 | 2025-01-17 |
Atlassian Corp
(TEAM)
|
PS Planned sale |
Cannon-Brookes Michael CEO, Co-Founder Executive Director Large shareholder |
2,897
-0.7%
253.05USD 733,078 |
2,897 -0.7% | 253.05 | USD 733,078 | |
2025-01-17 | 2025-01-17 |
Atlassian Corp
(TEAM)
|
PS Planned sale |
Cannon-Brookes Michael CEO, Co-Founder Executive Director Large shareholder |
1,757
-0.4%
254.00USD 446,273 |
1,757 -0.4% | 254.00 | USD 446,273 | |
2025-01-17 | 2025-01-17 |
Atlassian Corp
(TEAM)
|
PS Planned sale |
Cannon-Brookes Michael CEO, Co-Founder Executive Director Large shareholder |
150
-0.0%
254.85USD 38,228 |
150 -0.0% | 254.85 | USD 38,228 | |
2025-01-17 | 2025-01-17 |
Atlassian Corp
(TEAM)
|
PS Planned sale |
Cannon-Brookes Michael CEO, Co-Founder Executive Director Large shareholder |
100
-0.0%
258.43USD 25,843 |
100 -0.0% | 258.43 | USD 25,843 | |
2025-01-17 | 2025-01-17 |
Frontier Group Holdings Inc
(ULCC)
|
PS Planned sale |
Biffle Barry CEO Executive Director |
273,000
-25.1%
8.44USD 2,304,120 |
273,000 -25.1% | 8.44 | USD 2,304,120 | |
2025-01-17 | 2025-01-17 |
Atlassian Corp
(TEAM)
|
PS Planned sale |
BHARADWAJ ANUTTHARA President Officer |
1,520
-0.7%
259.85USD 394,972 |
1,520 -0.7% | 259.85 | USD 394,972 | |
2025-01-17 | 2025-01-17 |
Pro-Dex Inc
(PDEX)
|
PS Planned sale |
CABILLOT RAYMOND E Non-Executive Director Large shareholder |
4,013
-1.2%
45.18USD 181,307 |
4,013 -1.2% | 45.18 | USD 181,307 | |
2025-01-17 | 2025-01-17 |
Pro-Dex Inc
(PDEX)
|
PS Planned sale |
CABILLOT RAYMOND E Non-Executive Director Large shareholder |
2,807
-0.8%
44.40USD 124,631 |
2,807 -0.8% | 44.40 | USD 124,631 | |
2025-01-17 | 2025-01-17 |
Lifeway Foods Inc
(LWAY)
|
S Sale |
SMOLYANSKY LUDMILA |
12,034
-1.2%
22.55USD 271,367 |
12,034 -1.2% | 22.55 | USD 271,367 | |
2025-01-17 | 2025-01-17 | PS Planned sale |
KATHWARI M FAROOQ Chairman, President & CEO Executive Director Large shareholder |
175
-0.7%
28.67USD 5,017 |
175 -0.7% | 28.67 | USD 5,017 | ||
2025-01-17 | 2025-01-17 | PS Planned sale |
KATHWARI M FAROOQ Chairman, President & CEO Executive Director Large shareholder |
175
-0.7%
28.67USD 5,017 |
175 -0.7% | 28.67 | USD 5,017 | ||
2025-01-17 | 2025-01-17 | PS Planned sale |
KATHWARI M FAROOQ Chairman, President & CEO Executive Director Large shareholder |
175
-0.7%
28.67USD 5,017 |
175 -0.7% | 28.67 | USD 5,017 | ||
2025-01-17 | 2025-01-17 | PS Planned sale |
KATHWARI M FAROOQ Chairman, President & CEO Executive Director Large shareholder |
175
-0.7%
28.67USD 5,017 |
175 -0.7% | 28.67 | USD 5,017 | ||
2025-01-17 | 2025-01-17 | PS Planned sale |
KATHWARI M FAROOQ Chairman, President & CEO Executive Director Large shareholder |
10,000
-0.6%
28.67USD 286,700 |
10,000 -0.6% | 28.67 | USD 286,700 | ||
2025-01-17 | 2025-01-17 |
OPKO Health Inc
(OPK)
|
B Purchase |
FROST PHILLIP MD ET AL CEO & Chairman Executive Director Large shareholder |
150,000
+0.1%
1.47USD 220,425 |
150,000 +0.1% | 1.47 | USD 220,425 | |
2025-01-17 | 2025-01-17 |
Expensify Inc
(EXFY)
|
PS Planned sale |
Barrett David Michael Chief Executive Officer Executive Director |
32,473
-1.5%
3.41USD 110,733 |
32,473 -1.5% | 3.41 | USD 110,733 | |
2025-01-17 | 2025-01-17 | B Purchase |
Little Harrison James Executive Vice President Officer |
5,000
+inf%
13.04USD 65,193 |
5,000 +inf% | 13.04 | USD 65,193 | ||
2025-01-17 | 2025-01-17 |
Aldel Financial Inc
(ADF)
|
PS Planned sale |
KAUFFMAN ROBERT I Non-Executive Director |
2,407
-0.1%
9.69USD 23,324 |
2,407 -0.1% | 9.69 | USD 23,324 | |
2025-01-17 | 2025-01-17 |
Barnwell Industries Inc
(BRN)
|
B Purchase |
Hopkins Craig Douglas Chief Executive Officer Officer |
10,000
+7.1%
1.65USD 16,500 |
10,000 +7.1% | 1.65 | USD 16,500 | |
2025-01-17 | 2025-01-17 |
Coinbase Global Inc
(COIN)
|
PS Planned sale |
HAAS ALESIA J Chief Financial Officer Officer |
20,000
-13.8%
300.00USD 6,000,000 |
20,000 -13.8% | 300.00 | USD 6,000,000 | |
2025-01-17 | 2025-01-17 | S Sale |
SRIVASTAVA SUDHIR Chairman and CEO Executive Director Large shareholder |
364,431
-0.4%
1.37USD 499,999 |
364,431 -0.4% | 1.37 | USD 499,999 | ||
2025-01-17 | 2025-01-17 |
Mackenzie Realty Capital Inc
(NONE)
|
B Purchase |
DIXON ROBERT E CEO/President Officer |
15,000
+75.2%
2.55USD 38,250 |
15,000 +75.2% | 2.55 | USD 38,250 | |
2025-01-17 | 2025-01-17 |
Anixa Biosciences Inc
(ANIX)
|
B Purchase |
Titterton Lewis H jr Non-Executive Director |
10,000
+1.1%
2.57USD 25,700 |
10,000 +1.1% | 2.57 | USD 25,700 | |
2025-01-17 | 2025-01-16 |
Quantum Corp
(QMCO)
|
S Sale |
Gianella Kenneth P. Chief Financial Officer Officer |
1,487
-4.2%
35.68USD 53,056 |
1,487 -4.2% | 35.68 | USD 53,056 | |
2025-01-17 | 2025-01-16 |
Quantum Corp
(QMCO)
|
S Sale |
Spanjaard Henk Jan Chief Revenue Officer Officer |
935
-5.9%
35.68USD 33,361 |
935 -5.9% | 35.68 | USD 33,361 | |
2025-01-17 | 2025-01-16 |
New York City REIT Inc
(NYCI)
|
B Purchase |
SCHORSCH NICHOLAS S Large shareholder |
1,367
+0.1%
9.08USD 12,412 |
1,367 +0.1% | 9.08 | USD 12,412 | |
2025-01-17 | 2025-01-16 |
Quantum Corp
(QMCO)
|
S Sale |
Cabrera Brian E SVP Chief Admin Ofcr & Secy Officer |
1,996
-6.7%
35.68USD 71,217 |
1,996 -6.7% | 35.68 | USD 71,217 | |
2025-01-17 | 2025-01-16 |
Quantum Corp
(QMCO)
|
S Sale |
Lerner James J President & CEO Executive Director |
2,511
-2.3%
35.68USD 89,592 |
2,511 -2.3% | 35.68 | USD 89,592 | |
2025-01-17 | 2025-01-16 |
Primeenergy Resources Corp
(PNRG)
|
S Sale |
HURT CLINT Non-Executive Director |
739
-0.6%
214.86USD 158,782 |
739 -0.6% |